The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome

Cancer Genetics and Cytogenetics

Volumn 116, Issue 1, 2000, Pages 1-5

  Malkin, David ^a   Brown, Elizabeth J ^a   Zipursky, Alvin ^a  

^a Hospital for Sick   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ARTICLE; BLOOD ANALYSIS; BONE MARROW CELL; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DOWN SYNDROME; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LEUKEMIA; LEUKEMOGENESIS; MALE; MALIGNANT TRANSFORMATION; MEGAKARYOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ARGININE; BASE SEQUENCE; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; GENES, P53; GLYCINE; HUMANS; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MALE; MEGAKARYOCYTES; MUTATION; PROLINE; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53; VALINE;

EID: 0033991491     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00072-2     Document Type: Article

References (42)

1. Zipursky A., Peeters M., Poon A. Megakaryoblastic leukemia of Down's syndrome. Ped Hemat Oncol. 4:1987;211-230.
2. Zipursky A., Poon A., Doyle J. Leukemia in Down syndrome. A review. Ped Hemat Oncol. 9:1992;139-149.
3. Doyle J.J., Zipursky A. Down syndrome children with neonatal transient leukemia. survival and risk of subsequent myelodysplasia and leukemia Blood. 84:1994;316a.
4. Zipursky A., Rose T., Skidmore M., Thorner P., Doyle J. Hydrops fetalis and neonatal leukemia in Down syndrome. Ped Hem Oncol. 13:1996;81-87.
5. Miyauchi J., Ito Y., Kawano T., Tsunematsu Y., Shimizu K. Unusual diffuse liver fibrosis accompanying transient abnormal myelopoiesis in Down's syndrome. Blood. 80:1992;1521-1527.
6. Zipursky A., Christensen H., DeHarven E. Ultrastructural studies of the megakaryocytic leukemias of Down syndrome. Leuk Lymph. 18:1995;341-347.
7. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
8. Mowat M., Cheng A., Kimura N., Bernstein A., Benchimol S. Rearrangements of the cellular p53 gene in erythroleukemic cells transformed by Friend virus. Nature. 314:1985;633-636.
9. Baker S.J., Markowitz K., Fearon E.R., Wilson J.K.V., Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 249:1990;1912-1915.
10. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature. 351:1991;453-456.
11. Pines J. p21 inhibits cyclin shock. Nature. 369:1994;520-521.
12. Crook T., Marston N., Sara E., Vousden K. Transcriptional activation by p53 correlates with suppression of growth by not transformation. Cell. 79:1994;817-827.
13. Canman C., Gilmer E.T.M., Kastan M.B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:1995;600-611.
14. Schlichmeyer W.J., Nelson W.G., Slebos R.J., Kastan M.B. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53:1995;4164-4168.
15. Paules R.S., Levedakou E.N., Wilson S.J., Innes C.L., Rhodes N., Tlsty D., Galloway D.A., Donehower L.A., Tainsky M.A., Kaufmann W.K. Defective G2 checkpoint function in cells from individuals with familial cancer syndrome. Cancer Res. 55:1995;1763-1773.
16. Guillof C., Rosseli F., Krisnaraju K., Moustacchi E., Hoffman B., Liebermann D.A. p53 involvement in control of G2 exit of the cell cycle. role in DNA damage-induced apoptosis Oncogene. 10:1995;2263-2270.
17. Stewart N., Hicks G.G., Paraskevas F., Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene. 10:1995;109-115.
18. Wang Y., Prives C. Increased and altered DNA binding of human P53 by S and G2/M but not G1 cyclin-dependent kinases. Nature. 376:1995;88-91.
19. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
20. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
21. Caron de Fromentel C., Soussi T. TP53 suppressor gene. a model for investigating human mutagenesis Genes Chromosom Cancer. 4:1992;1-15.
22. Greenblatt M.A., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene. clues to cancer etiology and molecular pathogenesis Cancer Res. 54:1994;4855-4878.
23. Prokocimer M., Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells. projection to the hematologic cell lineages Blood. 84:1994;2391-2411.
24. Slingerland J.M., Mindern M.D., Benchimol S. Mutation of the p53-gene in human myelogenous leukemia. Blood. 77:1991;1500-1507.
25. Nakai H., Misawa S., Toguchida J., Yandell D.W., Ishizaki K. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Cancer Res. 52:1992;6588-6593.
26. Ichikawa A., Kinoshita T., Watanabe T., Kato H., Nagai H., Tsushita K., Saito H., Hotta T. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. New Engl J Med. 337:1997;529-534.
27. Sidransky D., Mikkelsen T., Schwechheimer K., Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature. 355:1992;846-847.
28. Baker S.J., Preisinger A.C., Jessup J.M., Vogelstein B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal carcinogenesis. Cancer Res. 50:1991;7717-7722.
29. Peng H.-Q., Hogg D., Malkin D., Bailey D., Gallie B.L., Bulbul M., Jewett M., Buchanan J., Goss P.E. Mutations of the p53 gene do not occur in testis cancer. Cancer Res. 53:1993;3574-3578.
30. Wagner J., Portwine C., Rabin K., Leclerc J.-M., Narod S.A., Malkin D. High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst. 86:1994;1707-1710.
31. Zipursky A., Rivard G., Freedman M.H. Differentiation of leukemic megakaryoblasts in Down syndrome. Blood. 80:1992;32a.
32. Bi S., Hughes T., Bungey J., Chase A., de Fabritiis P., Goldman J.M. p53 in chronic myeloid leukemia cell lines. Leukemia. 6:1992;839-842.
33. Sakashita A., Hattori T., Miller C.W., Suzushima H., Asou N., Takatsuki K., Koeffler H. Mutations of the p53 gene in adult T cell leukemia. Blood. 79:1992;477-480.
34. Jonveux Ph Fenaux P., Quiquandon I., Pignon J.M., Lai J.L., Loucheux-Lefebvre M.H., Goosens M., Bauters F., Berger R. Mutations in the p53 gene in myelodysplastic syndromes. Oncogene. 6:1991;2243-2247.
35. Felix C.A., Nau M.M., Takahashi T., Mitsudomi T., Chiba I., Poplack D.G., Reaman G.H., Cole D.E., Letterio J.J., Whang-Peng J., Knutsen T., Minna J.D. Hereditary and acquired p53 mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 89:1992;640-647.
36. Kastan M.B., Radin A.I., Kuerbitz S.J., Onyekwere O., Wolkow C.A., Civin C.I., Stone K.D., Woo T., Ravindranath Y., Craig R.W. Levels of p53 increase with maturation in human hematopoietic cells. Cancer Res. 51:1991;4279-4286.
37. Hollstein M., Rice K., Greenblatt M.S., Soussi T., Fuchs R., Sorlie T., Hovig E., Smith-Sorensen B., Montesano R., Harris C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucl Acids Res. 22:1994;3551-3555.
38. Iskioka C., Frebourg T., Yan Y.-X., Vidal M., Friend S.H., Schmidt S., Iggo R. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nature Genet. 5:1993;124-129.
39. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., Breuer J., Leigh I.M., Matlashewski G., Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 393:1998;229-234.
40. To-Figueres J., Gene M., Gomez-Catalan J., Galan C., Firvida J., Fuentes M., Rodamilans M., Huguet E., Estape J., Corbella J. Glutathione-S-transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomark Prevent. 5:1996;337-342.
41. Murata M., Tagawa M., Kimura M., Kimura H., Watanabe S., Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis. 17:1996;261-264.
42. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.